Triomics
UnknownCited oncology intelligence for clinical, registry, and trial workflows
Informações da ferramenta
O que é Triomics?
Triomics is an oncology intelligence platform that transforms cancer patient records into structured, cited insights. It supports clinical workflows, clinical trial matching, visit preparation, and cancer registry curation.
Recursos principais
Patient trial matching
Matches scheduled patients against active clinical trials and provides a prioritized candidate worklist with evidence from pathology, molecular, and clinical note details.
Visit preparation and pre-charting
Assembles patient snapshots with disease status, treatment timelines, and biomarkers, along with a completed pre-charting note within the workflow.
Cancer registry curation
Produces structured abstractions across NAACCR, SEER, CoC, and QOPI measures, linking each field to the corresponding source line in the patient chart.
Cross-record patient intelligence
Analyzes information across the full patient record to generate a structured, cited patient view for use before visits, during screening, and after appointments.
Casos de uso
- #1
Clinical trial screening
Help trial coordinators identify and prioritize potentially eligible patients from scheduled oncology visits.
- #2
Oncology visit preparation
Prepare clinicians for patient visits with disease status, treatment history, biomarker information, and pre-charting notes.
- #3
Cancer registry and quality reporting
Create cited abstractions for cancer registry and quality-improvement measures.
Planos de preços
Pricing is not clearly published by the official source.
Alternativas
Perguntas frequentes
What is Triomics?
What does Triomics support?
Can Triomics help with clinical trial screening?
Does Triomics support cancer registry work?
Who is Triomics for?
How much does Triomics cost?
How can I contact Triomics?
Triomics Contato e mídias sociais
- Telefone
- E-mail de suporte
- Suporte
- Site:
- Twitter
- LinkedIn
Comentários
Compartilhe sua experiência com esta ferramenta...


